Boston Scientific Corp. (BSX)

40.42
NYSE : Health Technology
Prev Close 40.66
Day Low/High 40.33 / 40.95
52 Wk Low/High 31.56 / 41.99
Avg Volume 8.44M
Exchange NYSE
Shares Outstanding 1.39B
Market Cap 56.54B
EPS 1.20
P/E Ratio 31.77
Div & Yield N.A. (N.A)

Latest News

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure To Direct Oral Anticoagulants For Stroke Risk Reduction Post-AFib Ablation

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure To Direct Oral Anticoagulants For Stroke Risk Reduction Post-AFib Ablation

Findings could expand number of patients who can receive alternative treatment to life-long use of blood thinners

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX) of the June 24, 2019 deadline to seek the role of lead plaintiff in a federal securities...

Boston Scientific To Participate In Bernstein's 35th Annual Strategic Decisions Conference

Boston Scientific To Participate In Bernstein's 35th Annual Strategic Decisions Conference

MARLBOROUGH, Mass., May 15, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 35 th Annual Strategic Decisions Conference on Wednesday, May 29, 2019 in New York City.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Boston Scientific Corporation Of Class Action Lawsuit And Upcoming Deadline - BSX

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Boston Scientific Corporation Of Class Action Lawsuit And Upcoming Deadline - BSX

NEW YORK, May 14, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:  BSX) and certain of its officers.

Late-Breaking Trial Data Highlight Continued Clinical Success Of Boston Scientific EMBLEM™ S-ICD System

Late-Breaking Trial Data Highlight Continued Clinical Success Of Boston Scientific EMBLEM™ S-ICD System

New data further support use of S-ICD System as first-line therapy for majority of ICD patients

Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.

Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.

Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies

Boston Scientific To Participate In The 2019 UBS Global Healthcare Conference

Boston Scientific To Participate In The 2019 UBS Global Healthcare Conference

MARLBOROUGH, Mass., May 7, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2019 UBS Global Healthcare Conference on Tuesday, May 21, 2019 in New York City.

Boston Scientific Receives U.S. FDA Approval For The VICI VENOUS STENT™ System

Boston Scientific Receives U.S. FDA Approval For The VICI VENOUS STENT™ System

New Stent System Now Available for Treating Patients with Deep Venous Blockages

Boston Scientific Announces Scheduled Presentations At Heart Rhythm 2019

Boston Scientific Announces Scheduled Presentations At Heart Rhythm 2019

MARLBOROUGH, Mass., May 1, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Heart Rhythm Scientific Sessions, in San Francisco on May...

Boston Scientific To Participate In Bank Of America Merrill Lynch Healthcare Conference 2019

Boston Scientific To Participate In Bank Of America Merrill Lynch Healthcare Conference 2019

MARLBOROUGH, Mass., May 1, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the Bank of America Merrill Lynch Healthcare Conference 2019 on Wednesday, May 15, 2019 in Las Vegas.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX) of the June 24, 2019 deadline to seek the role of lead plaintiff in a federal securities...

Boston Scientific Corp. Shareholder Alert: Securities Lawsuit Filed Against BSX

Boston Scientific Corp. Shareholder Alert: Securities Lawsuit Filed Against BSX

BOSTON, April 26, 2019 /PRNewswire/ -- Thornton Law Firm LLP announces that it is investigating a securities class action on behalf of shareholders and investors who purchased the securities of Boston Scientific Corporation (NYSE ticker: BSX).

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

NEW YORK, April 25, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX) of the June 24, 2019 deadline to seek the role of...

Johnson Fistel Announces Class Action Suit Against Boston Scientific Corporation (BSX); Encourages Investors To Contact The Firm For Additional Information

Johnson Fistel Announces Class Action Suit Against Boston Scientific Corporation (BSX); Encourages Investors To Contact The Firm For Additional Information

SAN DIEGO, April 25, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP reminds investors that a class action lawsuit has been filed against Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific") on behalf of all purchasers of...

Boston Scientific Announces Results For First Quarter 2019

Boston Scientific Announces Results For First Quarter 2019

MARLBOROUGH, Mass., April 24, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.

Boston Scientific Receives FDA Approval For LOTUS Edge™ Aortic Valve System

Boston Scientific Receives FDA Approval For LOTUS Edge™ Aortic Valve System

Transcatheter Aortic Valve Replacement Technology for Patients with Severe Aortic Stenosis Designed to Minimize Paravalvular Leakage, Offer Controlled Delivery and Repositionability Post Deployment

Lifshitz & Miller LLP Announces Investigation Of Advanced Disposal Services, Inc., Boston Scientific Corporation, Cavco Industries, Inc., Evoqua Water Technologies Corp., HomeFed Corporation, KeyW Holding Corporation, Level Brands, Inc., And Nightstar Therapeutics Plc.

Lifshitz & Miller LLP Announces Investigation Of Advanced Disposal Services, Inc., Boston Scientific Corporation, Cavco Industries, Inc., Evoqua Water Technologies Corp., HomeFed Corporation, KeyW Holding Corporation, Level Brands, Inc., And Nightstar Therapeutics Plc.

NEW YORK, April 23, 2019 /PRNewswire/ -- Advanced Disposal Services, Inc. (ADSW) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of ADSW to Waste Management, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Boston Scientific Corporation - BSX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Boston Scientific Corporation - BSX

NEW YORK, April 19, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).

Boston Scientific Announces Conference Call Discussing First Quarter 2019 Financial Results

Boston Scientific Announces Conference Call Discussing First Quarter 2019 Financial Results

MARLBOROUGH, Mass., March 27, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2019 on Wednesday, April 24, 2019 at...

Late-breaking Clinical Trial Highlights Positive Safety And Efficacy Data For The LUMINIZE™ RF Balloon Catheter

Late-breaking Clinical Trial Highlights Positive Safety And Efficacy Data For The LUMINIZE™ RF Balloon Catheter

New data showcasing performance of recently acquired RF balloon-based, single-shot ablation technology

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Company begins limited market release in Europe

Boston Scientific Announces Scheduled Data At EHRA 2019 Congress

Boston Scientific Announces Scheduled Data At EHRA 2019 Congress

MARLBOROUGH, Mass., March 11, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at EHRA 2019, the annual congress of the European Heart Rhythm Association (EHRA) in Lisbon, Portugal, on March...

Boston Scientific Prices $4.3 Billion Of Senior Notes

Boston Scientific Prices $4.3 Billion Of Senior Notes

MARLBOROUGH, Mass., Feb.

Boston Scientific Announces Results For Fourth Quarter And Full Year 2018

Boston Scientific Announces Results For Fourth Quarter And Full Year 2018

MARLBOROUGH, Mass., Feb.

TheStreet Quant Rating: B (Buy)